Nov
DEC
Jan
21
2014
2015
2016
1 captures
21 Dec 15 - 21 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Endocrinology
Canagliflozin Reduces HbA1C in Patients with Stage 3 CKD, with the Change Greater in Patients with Higher eGFR
Education Improves Hypoglycemia Awareness Regardless of Technology Used for Insulin Delivery
Cardiovascular Safety of Linagliptin in Patients with Type 2 Diabetes
DURATION-3 Trial Results
Empagliflozin Improves Glycemic Parameters and Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus
The Impact of Obesity, Hypertension, and Glycemia on CKD
Lifestyle Intervention Fails to Reduce Rate of CV Events in T2DM but Has Favorable Effect on other Measures
New Options in Insulin Pump Therapy
Update on the New Insulin Preparations
Hypotheses Explaining the Mystery of Diabetic Cardiomyopathy Include Fatty Acids, Transcription Factors
Pages
Previous
Next
1
…
7
8
9
10
11
12
13
14
15
